Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study

SARS-CoV-2 vaccination is the most effective strategy to protect individuals with haematologic malignancies against severe COVID-19, while eliciting limited vaccine responses. We characterized the humoral responses following 3 mo after mRNA-based vaccines in individuals at different plasma-cell dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Abella, Eugenia, Trigueros, Macedonia, Pradenas, Edwards, Muñoz-Lopez, Francisco, Garcia-Pallarols, Francesc, Ben Azaiz Ben Lahsen, Randa, Trinité, Benjamin, Urrea, Victor, Marfil, Silvia, Rovirosa, Carla, Puig, Teresa, Grau, Eulàlia, Chamorro, Anna, Toledo, Ruth, Font, Marta, Palacín, Dolors, Lopez-Segui, Francesc, Carrillo, Jorge, Prat, Nuria, Mateu, Lourdes, Clotet, Bonaventura, Blanco, Julià, Massanella, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375155/
https://www.ncbi.nlm.nih.gov/pubmed/35961779
http://dx.doi.org/10.26508/lsa.202201479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375155/
https://www.ncbi.nlm.nih.gov/pubmed/35961779
http://dx.doi.org/10.26508/lsa.202201479

Ejemplares similares